Neurofibromatosis Type 1 and Type 2

Displaying 1 - 10 of 10CSV
Robins, S. M., Rosenblatt, M., Bruce, J. N., Canoll, P., & Zanazzi, G. (2025). Solitary fibrous tumor in the pineal region: A series of 5 cases and literature review. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf008
Publication Date
Ager, C. R., Jugler, C., Zhu, Y., Chen, D., Athar, M., Izar, B., Bickers, D., & Kim, A. (2024). 791 Immunological correlates of response to vismodegib and PD-1 blockade in an autochthonous model of basal cell nevus (Gorlin-Goltz) syndrome. Regular and Young Investigator Award Abstracts, A896–A896. https://doi.org/10.1136/jitc-2024-sitc2024.0791
Publication Date
Hébert, J., De Santis, R. J., Daniyal, L., Mannan, S., Ng, E., Thain, E., Sanabria-Salas, M. C., Kim, R. H., Bril, V., & Reid, A. Y. (2024). Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults. Epilepsy Research, 202, 107336. https://doi.org/10.1016/j.eplepsyres.2024.107336
Publication Date
Guo, Y., Valk, J. E., Fecher, R., O’Toole, K., Saqi, A., & Sonett, J. (2023). Case of Metastatic Atypical Meningioma to Lung: Utility of Cytological Preparations for Intraoperative Diagnosis. American Journal of Clinical Pathology, 160(Supplement_1), S104–S104. https://doi.org/10.1093/ajcp/aqad150.228
Publication Date
Sedor, G. J., Lee, A. W., Gallitto, M., Pasetsky, J., Helis, C. A., Chan, M. D., Beckham, T., McGovern, S. L., & Wang, T. J. C. (2023). Multi-Institutional Study of Stereotactic Radiosurgery for Recurrent WHO Grade 2/3 Meningiomas: An Interim Analysis. International Journal of Radiation Oncology*Biology*Physics, 117(2), e148. https://doi.org/10.1016/j.ijrobp.2023.06.965
Publication Date
Kim, A., Zhu, Y., Chen, D., Elmais, M., Athar, M., & Bickers, D. R. (2023). LB1763 Combinatorial BRD9 and SMO targeting synergistically suppress UV-induced BCC tumor burden in a murine model of Gorlin syndrome (GS). Journal of Investigative Dermatology, 143(9), B28. https://doi.org/10.1016/j.jid.2023.06.143
Publication Date
Rodriguez, J., Martinez, G., Mahase, S., Roytman, M., Haghdel, A., Kim, S., Madera, G., Magge, R., Pan, P., Ramakrishna, R., Schwartz, T. H., Pannullo, S. C., Osborne, J. R., Lin, E., Knisely, J. P. S., Sanelli, P. C., & Ivanidze, J. (2023). Cost-Effectiveness Analysis of68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma. American Journal of Neuroradiology, 44(7), 783–791. https://doi.org/10.3174/ajnr.a7901
Publication Date
Argenziano, M. G., Furnari, J. L., Miller, M. L., Sun, Y., Banu, M. A., Neira, J. A., Snuderl, M., Bruce, J. N., Welch, M., McCormick, P., & Canoll, P. (2022). Thoracic low grade glial neoplasm with concurrent H3 K27M and PTPN11 mutations. Acta Neuropathologica Communications, 10(1). https://doi.org/10.1186/s40478-022-01340-9
Publication Date
Jia, L., Buss, E. J., Padilla, O., & Wang, T. J. C. (2022). Prospectively Observed Histopathologic Predictors of Progression after Stereotactic Radiosurgery for Recurrent Atypical Meningioma. International Journal of Radiation Oncology*Biology*Physics, 114(3), e43–e44. https://doi.org/10.1016/j.ijrobp.2022.07.770
Publication Date
Kumthekar, P., Grimm, S. A., Aleman, R. T., Chamberlain, M. C., Schiff, D., Wen, P. Y., Iwamoto, F. M., Gursel, D. B., Reardon, D. A., Purow, B., Kocherginski, M., Helenowski, I., & Raizer, J. J. (2022). A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncology Advances, 4(1). https://doi.org/10.1093/noajnl/vdac123
Publication Date